Renal cell carcinoma: Review of etiology, pathophysiology and risk factors
- PMID: 26558360
- DOI: 10.5507/bp.2015.050
Renal cell carcinoma: Review of etiology, pathophysiology and risk factors
Abstract
Background and aims: The global incidence of renal cell cancer is increasing annually and the causes are multifactorial. Early diagnosis and successful urological procedures with partial or total nephrectomy can be life-saving. However, only up to 10% of RCC patients present with characteristic clinical symptoms. Over 60% are detected incidentally in routine ultrasound examination. The question of screening and preventive measures greatly depends on the cause of the tumor development. For the latter reason, this review focuses on etiology, pathophysiology and risk factors for renal neoplasm.
Methods: A literature search using the databases Medscape, Pubmed, UpToDate and EBSCO from 1945 to 2015.
Results and conclusions: Genetic predisposition/hereditary disorders, obesity, smoking, various nephrotoxic industrial chemicals, drugs and natural/manmade radioactivity all contribute and enviromental risks are a serious concern in terms of prevention and the need to screen populations at risk. Apropos treatment, current oncological research is directed to blocking cancer cell division and inhibiting angiogenesis based on a knowledge of molecular pathways.
Keywords: hereditary syndromes; nephrectomy; radioactivity; renal carcinogenesis; renal cell carcinoma; uranium toxicity.
Similar articles
-
Renal cell carcinoma: progress against an elusive tumor.Semin Oncol. 2000 Apr;27(2):113-4. Semin Oncol. 2000. PMID: 10768590 No abstract available.
-
Diagnosis and Management of Hereditary Renal Cell Cancer.Recent Results Cancer Res. 2016;205:85-104. doi: 10.1007/978-3-319-29998-3_6. Recent Results Cancer Res. 2016. PMID: 27075350
-
Contemporary management of advanced renal cell carcinoma.Clin Adv Hematol Oncol. 2018 Jun;16(6):438-446. Clin Adv Hematol Oncol. 2018. PMID: 30067615
-
Renal cell carcinoma: current status and emerging therapies.Cancer Treat Rev. 2007 May;33(3):299-313. doi: 10.1016/j.ctrv.2006.12.005. Epub 2007 Feb 27. Cancer Treat Rev. 2007. PMID: 17329029 Review.
-
Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review.Cancer Invest. 2005;23(3):240-55. doi: 10.1081/cnv-200055962. Cancer Invest. 2005. PMID: 15945510 Review.
Cited by
-
Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer.Int J Mol Sci. 2023 Sep 28;24(19):14713. doi: 10.3390/ijms241914713. Int J Mol Sci. 2023. PMID: 37834162 Free PMC article. Review.
-
A Neurosurgical Perspective on Brain Metastases from Renal Cell Carcinoma: Multi-Institutional, Retrospective Analysis.Biomedicines. 2023 Sep 7;11(9):2485. doi: 10.3390/biomedicines11092485. Biomedicines. 2023. PMID: 37760926 Free PMC article.
-
An Overview of Systemic Targeted Therapy in Renal Cell Carcinoma, with a Focus on Metastatic Renal Cell Carcinoma and Brain Metastases.Curr Issues Mol Biol. 2023 Sep 21;45(9):7680-7704. doi: 10.3390/cimb45090485. Curr Issues Mol Biol. 2023. PMID: 37754269 Free PMC article. Review.
-
Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma.Sci Rep. 2023 Jul 19;13(1):11668. doi: 10.1038/s41598-023-38914-z. Sci Rep. 2023. PMID: 37468683 Free PMC article.
-
MicroRNA-372 acts as a double-edged sword in human cancers.Heliyon. 2023 May 9;9(5):e15991. doi: 10.1016/j.heliyon.2023.e15991. eCollection 2023 May. Heliyon. 2023. PMID: 37251909 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical